Skip to main content

Nadolol Side Effects

Medically reviewed by Drugs.com. Last updated on Jan 18, 2024.

Applies to nadolol: oral tablet.

Warning

Oral route (Tablet)

Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. The dosage should be gradually reduced over a period of 1 to 2 weeks and the patient should be carefully monitored when discontinuing chronic therapy, particularly in patients with ischemic heart disease. If angina markedly worsens or acute coronary insufficiency develops, nadolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician's advice.

Serious side effects of Nadolol

Along with its needed effects, nadolol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking nadolol:

Less common

Rare

Other side effects of Nadolol

Some side effects of nadolol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Rare

For Healthcare Professionals

Applies to nadolol: compounding powder, oral tablet.

General

The most common adverse reactions were bradycardia, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency, hypotension, dizziness, and fatigue.[Ref]

Cardiovascular

Common (1% to 10%): Heart rate less than 60 beats per minute (bpm), heart rate less than 40 bpm, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency usually of the Raynaud type, hypotension

Frequency not reported: First degree and third degree heart block, cold extremities[Ref]

Nervous system

Common (1% to 10%): Dizziness

Uncommon (0.1% to 1%): Paresthesias, sedation, headache, slurred speech, tinnitus

Frequency not reported: Lightheadedness[Ref]

Other

Common (1% to 10%): Fatigue[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Nausea, diarrhea, abdominal discomfort, constipation, vomiting, indigestion, bloating, flatulence, dry mouth[Ref]

Dermatologic

Uncommon (0.1% to 1%): Rash, pruritus, dry skin, sweating, facial swelling

Frequency not reported: Reversible alopecia[Ref]

Respiratory

Uncommon (0.1% to 1%): Cough, nasal stuffiness, bronchospasm[Ref]

Metabolic

Uncommon (0.1% to 1%): Anorexia, weight gain

Frequency not reported: Hypoglycemia[Ref]

Ocular

Uncommon (0.1% to 1%): Dry eyes, blurred vision[Ref]

Psychiatric

Uncommon (0.1% to 1%): Change in behavior

Frequency not reported: Insomnia[Ref]

Genitourinary

Uncommon (0.1% to 1%): Impotence or decreased libido[Ref]

References

1. Product Information. Corgard (nadolol). Bristol-Myers Squibb. 2002;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer